250 related articles for article (PubMed ID: 30288660)
81. Enoxaparin reduces hepatic vascular resistance and portal pressure in cirrhotic rats.
Cerini F; Vilaseca M; Lafoz E; García-Irigoyen O; García-Calderó H; Tripathi DM; Avila M; Reverter JC; Bosch J; Gracia-Sancho J; García-Pagán JC
J Hepatol; 2016 Apr; 64(4):834-42. PubMed ID: 26686269
[TBL] [Abstract][Full Text] [Related]
82. Effects of armepavine against hepatic fibrosis induced by thioacetamide in rats.
Weng TC; Shen CC; Chiu YT; Lin YL; Huang YT
Phytother Res; 2012 Mar; 26(3):344-53. PubMed ID: 21717514
[TBL] [Abstract][Full Text] [Related]
83. Valproate ameliorates thioacetamide-induced fibrosis by hepatic stellate cell inactivation.
Aher JS; Khan S; Jain S; Tikoo K; Jena G
Hum Exp Toxicol; 2015 Jan; 34(1):44-55. PubMed ID: 24812151
[TBL] [Abstract][Full Text] [Related]
84. Vitamin D inhibits development of liver fibrosis in an animal model but cannot ameliorate established cirrhosis.
Abramovitch S; Sharvit E; Weisman Y; Bentov A; Brazowski E; Cohen G; Volovelsky O; Reif S
Am J Physiol Gastrointest Liver Physiol; 2015 Jan; 308(2):G112-20. PubMed ID: 25214398
[TBL] [Abstract][Full Text] [Related]
85. Pharmacological inhibition of integrin alphavbeta3 aggravates experimental liver fibrosis and suppresses hepatic angiogenesis.
Patsenker E; Popov Y; Stickel F; Schneider V; Ledermann M; Sägesser H; Niedobitek G; Goodman SL; Schuppan D
Hepatology; 2009 Nov; 50(5):1501-11. PubMed ID: 19725105
[TBL] [Abstract][Full Text] [Related]
86. Maltol Mitigates Thioacetamide-induced Liver Fibrosis through TGF-β1-mediated Activation of PI3K/Akt Signaling Pathway.
Mi XJ; Hou JG; Jiang S; Liu Z; Tang S; Liu XX; Wang YP; Chen C; Wang Z; Li W
J Agric Food Chem; 2019 Feb; 67(5):1392-1401. PubMed ID: 30644744
[TBL] [Abstract][Full Text] [Related]
87. Curcumin reduces Ly6C
Zhao XA; Chen G; Liu Y; Chen Y; Wu H; Xiong Y; Wang G; Jia B; Li Y; Xia J; Wang J; Yan X; Zhang Z; Huang R; Wu C
Biomed Pharmacother; 2018 Oct; 106():868-878. PubMed ID: 30119257
[TBL] [Abstract][Full Text] [Related]
88. Population of hepatic macrophages and response of perfused liver to platelet-activating factor during production of thioacetamide-induced cirrhosis in rats.
Noda S; Masumi S; Moriyama M; Kannan Y; Ohta M; Sugano T; Yamate J
Hepatology; 1996 Aug; 24(2):412-8. PubMed ID: 8690413
[TBL] [Abstract][Full Text] [Related]
89. Ingestion of mannose ameliorates thioacetamide-induced intrahepatic oxidative stress, inflammation and fibrosis in rats.
Shaker ME; Eisa NH; Elgaml A; El-Mesery A; El-Shafey M; El-Dosoky M; El-Mowafy M; El-Mesery M
Life Sci; 2021 Dec; 286():120040. PubMed ID: 34637794
[TBL] [Abstract][Full Text] [Related]
90. Amiloride reduces portal hypertension in rat liver cirrhosis.
Steib CJ; Hennenberg M; Beitinger F; Hartmann AC; Bystron M; De Toni EN; Gerbes AL
Gut; 2010 Jun; 59(6):827-36. PubMed ID: 20551467
[TBL] [Abstract][Full Text] [Related]
91. Dietary α-Lactalbumin protects against thioacetamide-induced liver cirrhosis by maintaining gut-liver axis function in rats.
Fukawa A; Baba S; Iwasawa K; Yamaguchi M; Hosono A
Biosci Biotechnol Biochem; 2020 Jan; 84(1):171-177. PubMed ID: 31476130
[TBL] [Abstract][Full Text] [Related]
92. Gingerol protects against experimental liver fibrosis in rats via suppression of pro-inflammatory and profibrogenic mediators.
Algandaby MM; El-Halawany AM; Abdallah HM; Alahdal AM; Nagy AA; Ashour OM; Abdel-Naim AB
Naunyn Schmiedebergs Arch Pharmacol; 2016 Apr; 389(4):419-28. PubMed ID: 26809353
[TBL] [Abstract][Full Text] [Related]
93. P2X7R orchestrates the progression of murine hepatic fibrosis by making a feedback loop from macrophage to hepatic stellate cells.
Jiang M; Cui BW; Wu YL; Zhang Y; Shang Y; Liu J; Yang HX; Qiao CY; Zhan ZY; Ye H; Jin Q; Nan JX; Lian LH
Toxicol Lett; 2020 Oct; 333():22-32. PubMed ID: 32721574
[TBL] [Abstract][Full Text] [Related]
94. Serelaxin increases the antifibrotic action of rosiglitazone in a model of hepatic fibrosis.
Bennett RG; Simpson RL; Hamel FG
World J Gastroenterol; 2017 Jun; 23(22):3999-4006. PubMed ID: 28652653
[TBL] [Abstract][Full Text] [Related]
95. Antifibrotic effect of meloxicam in rat liver: role of nuclear factor kappa B, proinflammatory cytokines, and oxidative stress.
Hassan MH; Ghobara MM
Naunyn Schmiedebergs Arch Pharmacol; 2016 Sep; 389(9):971-83. PubMed ID: 27245167
[TBL] [Abstract][Full Text] [Related]
96. Molecular mechanisms in thioacetamide-induced acute and chronic liver injury models.
Ezhilarasan D
Environ Toxicol Pharmacol; 2023 Apr; 99():104093. PubMed ID: 36870405
[TBL] [Abstract][Full Text] [Related]
97. An endothelin receptor antagonist TAK-044 ameliorates carbon tetrachloride-induced acute liver injury and portal hypertension in rats.
Gandhi CR; Nemoto EM; Watkins SC; Subbotin VM
Liver; 1998 Feb; 18(1):39-48. PubMed ID: 9548266
[TBL] [Abstract][Full Text] [Related]
98. Green tea polyphenol decreases the severity of portosystemic collaterals and mesenteric angiogenesis in rats with liver cirrhosis.
Hsu SJ; Wang SS; Hsin IF; Lee FY; Huang HC; Huo TI; Lee WS; Lin HC; Lee SD
Clin Sci (Lond); 2014 May; 126(9):633-44. PubMed ID: 24063570
[TBL] [Abstract][Full Text] [Related]
99. Anti-fibrotic effects of Cuscuta chinensis with in vitro hepatic stellate cells and a thioacetamide-induced experimental rat model.
Kim JS; Koppula S; Yum MJ; Shin GM; Chae YJ; Hong SM; Lee JD; Song M
Pharm Biol; 2017 Dec; 55(1):1909-1919. PubMed ID: 28651481
[TBL] [Abstract][Full Text] [Related]
100. Silent information regulator 1 (SIRT1) ameliorates liver fibrosis via promoting activated stellate cell apoptosis and reversion.
Wu Y; Liu X; Zhou Q; Huang C; Meng X; Xu F; Li J
Toxicol Appl Pharmacol; 2015 Dec; 289(2):163-76. PubMed ID: 26435214
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
